基因测序技术公司Illumina（ILMN）今日盘中大跌5.03%，尽管公司最新公布的季度业绩略微超出市场预期。这一走势引发了投资者对公司未来发展的担忧。
根据公司发布的财报，截至3月31日的季度调整后每股收益为0.97美元，高于分析师平均预期的0.94美元。营收为10.4亿美元，同比下降3.3%，但仍略高于分析师预期的10.3亿美元。尽管业绩表现优于预期，但投资者似乎对公司的长期前景持谨慎态度。
值得注意的是，Illumina股价今年迄今已下跌42.9%，反映出公司面临的持续挑战。分析师在过去三个月内下调了对公司的盈利预期，平均预期下降约3.6%。此外，近30天内有两位分析师对盈利预测进行了负面修正，这可能进一步加剧了投资者的担忧。虽然分析师对该公司的平均评级仍为"买入"，但市场似乎需要更多积极信号来重建信心。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.